While these studies do not exclude the possibility that the limited tumor growth in the shRNA-TrkB cells was due in part to the partial loss of TrkB function in the tumor cells, the magnitude of the impact on lymphatic metastasis cannot be explained entirely by the loss of TrkB. The gene discussed is NTRK2; the disease is neoplasm.